Difference between revisions of "Main Page"
Jump to navigation
Jump to search
Mobile/tablet version of the main page
Browse our complete index of pages
m |
|||
| Line 5: | Line 5: | ||
{| border="1" style="text-align:center;" | {| border="1" style="text-align:center;" | ||
!colspan="4" align="center" style="background-color:#0066FF"| Quick links to chemotherapy regimens | !colspan="4" align="center" style="background-color:#0066FF"| Quick links to chemotherapy regimens | ||
| + | |- | ||
| + | |colspan="4" align="center" style="background-color:#0066FF"| '''Solid tumors''' | ||
| + | |- | ||
| + | |[[Anal cancer]] | ||
| + | |[[Bladder cancer]] | ||
| + | |[[Bone cancer]] | ||
| + | |[[Breast cancer]] | ||
| + | |- | ||
| + | |[[Central nervous system (CNS) cancer]] | ||
| + | |[[Cervical cancer]] | ||
| + | |[[Colon cancer]] | ||
| + | |[[Esophageal cancer]] | ||
| + | |- | ||
| + | |[[Gastric cancer]] | ||
| + | |[[Head and neck cancer]] | ||
| + | |[[Hepatobiliary cancer]] | ||
| + | |[[Non-small cell lung cancer | Lung cancer, non-small cell]] | ||
| + | |- | ||
| + | |[[Small cell lung cancer | Lung cancer, small cell]] | ||
| + | |[[Melanoma]] | ||
| + | |[[Mesothelioma]] | ||
| + | |[[Neuroendocrine tumors]] | ||
| + | |- | ||
| + | |[[Basal cell and squamous cell skin cancer | Skin, basal & squamous cancer]] | ||
| + | |[[Ovarian cancer]] | ||
| + | |[[Pancreatic cancer]] | ||
| + | |[[Penile cancer]] | ||
| + | |- | ||
| + | |[[Prostate cancer]] | ||
| + | |[[Rectal cancer]] | ||
| + | |[[Renal cancer]] | ||
| + | |[[Sarcoma]] | ||
| + | |- | ||
| + | |[[Testicular cancer]] | ||
| + | |[[Thymoma]] | ||
| + | |[[Thyroid cancer]] | ||
| + | |[[Unknown primary]] | ||
| + | |- | ||
| + | |[[Uterine cancer]] | ||
|- | |- | ||
|colspan="4" align="center" style="background-color:#FF0D00"| '''Acute leukemias''' | |colspan="4" align="center" style="background-color:#FF0D00"| '''Acute leukemias''' | ||
| Line 66: | Line 105: | ||
|[[Paroxysmal nocturnal hemoglobinuria (PNH)]] | |[[Paroxysmal nocturnal hemoglobinuria (PNH)]] | ||
|[[Venous thromboembolism (VTE)]] | |[[Venous thromboembolism (VTE)]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|- | |- | ||
|} | |} | ||
| Line 113: | Line 113: | ||
break=no | break=no | ||
</inputbox> | </inputbox> | ||
| − | Any information that one feels would be helpful to other oncology providers is welcome. Visit [[how to contribute]] for more details. | + | Any information that one feels would be helpful to other oncology providers is welcome. Visit [[how to contribute]] for more details. Priorities of this project include: |
#Creating a database of [[Drug index | chemotherapy agents and other medications]]. | #Creating a database of [[Drug index | chemotherapy agents and other medications]]. | ||
| − | + | #Creating a database of chemotherapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles). | |
| − | #Creating a | ||
#[[:Category:Example chemotherapy order sets|Sample order sets]] and examples of supportive medications used with treatment regimens | #[[:Category:Example chemotherapy order sets|Sample order sets]] and examples of supportive medications used with treatment regimens | ||
#Aggregating [[External links|useful links]] to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources. | #Aggregating [[External links|useful links]] to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources. | ||
| Line 126: | Line 125: | ||
#Checklists for common clinical scenarios/diseases | #Checklists for common clinical scenarios/diseases | ||
#Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects | #Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects | ||
| − | |||
| − | |||
| − | |||
The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as [http://en.wikipedia.org/wiki/Main_Page Wikipedia], will significantly help ease-of-use and navigation. | The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as [http://en.wikipedia.org/wiki/Main_Page Wikipedia], will significantly help ease-of-use and navigation. | ||
If you would like to contribute, please create an account in the upper right corner, and send a message to [email protected] so that your account can be set up with the necessary rights. Due to the sensitive nature of the information contained within this site, unverified users will not be allowed to edit articles. | If you would like to contribute, please create an account in the upper right corner, and send a message to [email protected] so that your account can be set up with the necessary rights. Due to the sensitive nature of the information contained within this site, unverified users will not be allowed to edit articles. | ||
Revision as of 05:53, 2 February 2015
HemOnc.org - A Free Hematology/Oncology Reference
Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers and allows people to share wisdom and insights from their own clinical experiences for the benefit of all. This shared online notebook will continue to evolve and grow to meet the needs of the community because users such as yourself are able to refine and build upon existing content.
Browse our complete index of pages
Any information that one feels would be helpful to other oncology providers is welcome. Visit how to contribute for more details. Priorities of this project include:
- Creating a database of chemotherapy agents and other medications.
- Creating a database of chemotherapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
- Sample order sets and examples of supportive medications used with treatment regimens
- Aggregating useful links to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources.
Additional possibilities for this project may include:
- Creating summaries of pivotal clinical trials
- Establishing homepages for ongoing clinical trials that contain information and sites of participation
- Checklists for common clinical scenarios/diseases
- Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects
The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.
If you would like to contribute, please create an account in the upper right corner, and send a message to [email protected] so that your account can be set up with the necessary rights. Due to the sensitive nature of the information contained within this site, unverified users will not be allowed to edit articles.